Nicole Rodriguez-Borasz
Family · Dayton, OHNPI 1952848335
Payments from drug & device makers
Across 32 payments — averaging $53.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Procept Biorobotics Corporation$120
- Pharmacyclics LLC, An Abbvie Company$113
- Axonics, Inc.$53
- Teleflex LLC$12
Across 1 payment — averaging $70.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$70
What the payments were for
- Travel & lodging$89952%
- Food & beverage$80146%
- Education$272%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 24 | $1,430 |
| Procept Biorobotics Corporation | 1 | $120 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $113 |
| Axonics, Inc. | 1 | $53 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,030
- AQUABEAM SYSTEM$120
- INTELLIS ADAPTIVESTIM$116
How this compares
$1,728 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 94 | $58,841 |
| GemtesaVibegron | 31 | $28,942 |
| Estradiol | 61 | $3,626 |
| Methenamine Hippurate | 48 | $3,312 |
| Finasteride | 210 | $2,559 |
| Tamsulosin Hcl | 275 | $2,514 |
| Solifenacin Succinate | 28 | $2,019 |
| Darifenacin ErDarifenacin Hydrobromide | 14 | $1,800 |
| Tadalafil | 13 | $1,627 |
| Trospium Chloride | 24 | $1,053 |
| Oxybutynin Chloride ErOxybutynin Chloride | 46 | $618 |
| Testosterone Cypionate | 19 | $358 |
| CefuroximeCefuroxime Axetil | 13 | $330 |
| Levofloxacin | 36 | $166 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 22 | $163 |
Paid to pharmacies, not to this prescriber.
Other family in Dayton
- Leigh Ann PanschDayton$670K
- Amy RossDayton$281K
- Eileen FauldsLewis Center$991K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.